Back to News
Market Impact: 0.12

Congress rejects President Trump's deep NASA budget cuts, proposes $24.4 billion for the agency

Fiscal Policy & BudgetRegulation & LegislationElections & Domestic PoliticsTechnology & InnovationInfrastructure & Defense
Congress rejects President Trump's deep NASA budget cuts, proposes $24.4 billion for the agency

Congress has proposed $24.4 billion for NASA in FY2026, rejecting the White House's $18.8 billion request (a 24% cut) and restoring substantial science funding after a proposed reduction to $3.9 billion. The legislative plan would fund NASA science at $7.25 billion, including $500 million for the Dragonfly Titan mission and $300 million to complete the Nancy Grace Roman Space Telescope, but it does not support current construction of the Mars Sample Return campaign. The measure still requires House and Senate votes and the president's signature; implications include preserved cash flows for NASA science contractors and potential program redesign or reprioritization for Mars sample return if dedicated funding remains absent.

Analysis

Winners are prime aerospace/space contractors and specialist suppliers — think Lockheed Martin (LMT), Northrop Grumman (NOC), RTX (RTX) and satellite/mission specialists such as Maxar (MAXR) and Rocket Lab (RKLB) — because Congress restored ~$5.6B above the White House request and explicitly funded $7.25B for science (including $500M for Dragonfly and $300M for Roman). Direct losers include vendors and programs tied to the cancelled/paused Mars Sample Return (MSR) pipeline; smaller MSR subcontractors face multi-quarter revenue deferrals and re-bid risk. Competitive dynamics tilt in favor of incumbents with proven NASA program experience: primes gain pricing power on large systems integration work while boutique providers of scientific instruments see sequential order flow (expect procurement notices in 3–12 months). Supply/demand for launch capacity and deep-space instrumentation increases modestly — incremental revenue for launch providers and suppliers could be 1–3% of FY revenue for mid‑cap specialists over 24–48 months. Cross-asset: the budget uptick is too small to move broad rates materially but raises marginal long-duration Treasury issuance risk; expect a small (~5–15bp) upward tilt in 10Y yields if broader fiscal tightening follows. Tail risks: (1) House/Senate procedural derails or Presidential veto in next 2–3 weeks, (2) program cost overruns prompting mid-cycle cuts, (3) geopolitical shocks that reprioritize defense vs science spend. Immediate catalyst timeline: budget votes in days–weeks; RFPs/awards 3–12 months; Dragonfly launch 2028 and Roman telescope near-term spending through fall 2026. Hidden dependencies include DoD priorities, commercial launch cadence (SpaceX market share), and international partner contributions that can reallocate cost burdens. Contrarian view: the market underprices small/mid-cap specialist exposure tied to restored NASA science budgets — consensus favors primes only. A pairs/option approach that mildly leverages specialists (MAXR, RKLB) vs. broad travel/consumer space names (SPCE) captures this asymmetry; if appropriations fail within 30 days, cut exposure by 50% and rotate to defense primes which are stickier.